Generic Pharmaceuticals Business for Sale in Una, India
GMP-compliant pharmaceutical manufacturing unit in Himachal Pradesh with strong third-party revenues, available for outright sale.
Premium Plan
| Established | 1-5 year(s) |
| Employees | 10 - 50 |
| Legal Entity | General Partnership |
| Reported Sales | USD 1 - 2 million |
| Run Rate Sales | USD 1.6 million |
| EBITDA Margin | 10 - 20 % |
| Industries | Generic Pharmaceuticals |
| Locations | Una |
| Local Time | 11:51 AM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Full Sale
Asking Price:
USD
2.4 million
(Native Currency: INR 220,000,000)
Reason: The promoters are shifting focus to another business vertical in their hometown, while the next gene...
View More
Includes physical assets worth
USD
2 million
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Not disclosed
User Verification
Documents
GST Certificate
(106.0 KB)
Business Overview
• Established pharmaceutical formulation manufacturing unit located in Una district, Himachal Pradesh.
• Operates from a built-up facility of approximately 21,000 sq. ft. across two floors.
• Infrastructure is expandable up to double the existing built-up area.
• Separate, dedicated production blocks for general formulations and beta-lactam formulations.
• Manufactures tablets, capsules, liquids, ointments, and dry syrups.
• Licensed to manufacture approximately 1,000 formulations across multiple therapeutic segments.
• Product portfolio spans general, diabetic care, neuro-psychiatry, nephrology, gynaecology, orthopaedic, pediatric, and other specialities.
• No NSQ (Not of Standard Quality) record for any product to date.
• Installed annual capacity supports turnover of INR 50–60 crore in a single shift.
• Currently operates at around 25% capacity with an annual turnover of INR 12–14 crore.
• Over 80% of revenue is generated through third-party manufacturing contracts.
• Maintains strong working capital discipline with 100% debtor recovery within 60 days.
• Enjoys favourable creditor terms with approximately 90-day payment cycles.
• Equipped with a fully functional in-house Quality Control laboratory.
• QC facilities include chemical, instrumental, and microbiological testing along with stability study instruments.
• Offers significant growth potential with up to threefold scale-up through higher capacity utilization.
• Holds GMP and GLP certifications compliant with revised Schedule M standards. Does not hold USFDA approval.
• Operates from a built-up facility of approximately 21,000 sq. ft. across two floors.
• Infrastructure is expandable up to double the existing built-up area.
• Separate, dedicated production blocks for general formulations and beta-lactam formulations.
• Manufactures tablets, capsules, liquids, ointments, and dry syrups.
• Licensed to manufacture approximately 1,000 formulations across multiple therapeutic segments.
• Product portfolio spans general, diabetic care, neuro-psychiatry, nephrology, gynaecology, orthopaedic, pediatric, and other specialities.
• No NSQ (Not of Standard Quality) record for any product to date.
• Installed annual capacity supports turnover of INR 50–60 crore in a single shift.
• Currently operates at around 25% capacity with an annual turnover of INR 12–14 crore.
• Over 80% of revenue is generated through third-party manufacturing contracts.
• Maintains strong working capital discipline with 100% debtor recovery within 60 days.
• Enjoys favourable creditor terms with approximately 90-day payment cycles.
• Equipped with a fully functional in-house Quality Control laboratory.
• QC facilities include chemical, instrumental, and microbiological testing along with stability study instruments.
• Offers significant growth potential with up to threefold scale-up through higher capacity utilization.
• Holds GMP and GLP certifications compliant with revised Schedule M standards. Does not hold USFDA approval.
Products & Services Overview
Third-party pharmaceutical formulation manufacturing for domestic pharma companies across general and beta-lactam segments.
Assets Overview
- Tangible assets.• Plant.
• Machinery.
• Furniture.
• Fixtures.
• Laboratory equipment.
• Raw material stock.
• Packing material stock of 1500 brands.
• HVAC systems.
• DM water plant & ETP plant.
- Intangible assets:
• 1000+ product approvals.
• GST, GMP & GLP and Neutral Code certifications.
• Goodwill for 90-days credit facility from vendors.
• GST refund of approx. INR 1 crore.
Facilities Overview
Owned premises with a built‑up area of 22,000 sq. ft. across two floors, expandable up to double within available space. Strategically located on a well‑connected industrial plot allotted by the Directorate of Industries, Himachal Pradesh, with a sanctioned electrical load supported by a 400 kW transformer.
Capitalization Overview
100% Family business.Negligible term loan.
Can be handed over as an debt free entity.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
32 Buyers viewed this Business this week.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 64,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses